Maravai LifeSciences Holdings, Inc. (MRVI)

SpringWorks Therapeutics Revenue

Maravai LifeSciences Holdings had revenue of $46.85M in the quarter ending March 31, 2025, a decrease of -27.00%. This brings the company's revenue in the last twelve months to $241.86M, down -11.76% year-over-year. In the year 2024, Maravai LifeSciences Holdings had annual revenue of $259.19M, down -10.30%.

• Revenue (ttm): $241.86M
• Revenue Growth: -11.76%
• P/S Ratio: 1.29
• Revenue / Employee: $424,309
• Employees: 570
• Market Cap: 556.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	259.19M	-29.76M	-10.30%
Dec 31, 2023	288.95M	-594.06M	-67.28%
Dec 31, 2022	883.00M	83.76M	10.48%
Dec 31, 2021	799.24M	515.14M	181.33%
Dec 31, 2020	284.10M	140.96M	98.48%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.